New therapeutic possibilities for vein graft disease in the post-edifoligide era

ISSN： 1479-6678

Source： Future Cardiology, Vol.2, Iss.4, 2006-07, pp. : 493-501

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Saphenous Vein Graft Disease and Serum Erythropoietin Level

Medical Principles and Practice, Vol. 25, Iss. 5, 2016-03 ,pp. : 498-498

Karger

Access to resources Recommend Favorite

The Pathobiology of Endothelin-1 in Vein Graft Disease: Are ETA Receptor Antagonists the Solution to Prevent Vein Graft Failure?

Current Vascular Pharmacology, Vol. 3, Iss. 4, 2005-10 ,pp. : 315-323

Bentham Science Publishers

Access to resources Recommend Favorite

Plateletcrit: A platelet marker associated with saphenous vein graft disease

By Akpinar I. Sayin M.R. Gursoy Y.C. Karabag T. Kucuk E. Buyukuysal M.C. Aydin M. Haznedaroglu I.C.

Herz, Vol. 39, Iss. 1, 2014-02 ,pp. : 142-148

Springer Publishing Company

Access to resources Recommend Favorite

Saphenous Vein Graft Disease Is Associated with a Low Serum Erythropoietin Level

Medical Principles and Practice, Vol. 24, Iss. 6, 2015-0 ,pp. : 544-547

Karger

Access to resources Recommend Favorite

Editorial [Hot topic:Vascular Protective Effects of Ezetimibe: Seeking New Therapeutic Possibilities of Ezetimibe in Vascular Disease (Guest Editor: Minako Yamaoka-Tojo)]

Current Vascular Pharmacology, Vol. 9, Iss. 1, 2011-01 ,pp. : 61-61

Bentham Science Publishers

Access to resources Recommend Favorite